195 results on '"Levings, Megan K."'
Search Results
2. PHLPP Signaling in Immune Cells
3. Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes
4. 1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study
5. First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
6. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection
7. Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
8. Transduction of Human T Cell Subsets with Lentivirus
9. A germline heterozygous dominant negativeIKZF2variant causing syndromic primary immune regulatory disorder and ICHAD
10. 3D genomic features across >50 diverse cell types reveal insights into the genomic architecture of childhood obesity
11. Human A2-CAR T Cells Reject HLA-A2+ Human Islets Transplanted Into Mice Without Inducing Graft-versus-host Disease
12. Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults > 50 years: a prospective, observational cohort study
13. Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes in mice
14. Alleviating graft-versus-host disease by directing regulatory T cells to the gut … It is all about location, location, location
15. Eras of designer Tregs: Harnessing synthetic biology for immune suppression
16. Regulatory T Cell Biomarkers Identify Patients at Risk of Developing Acute Cellular Rejection in the First Year Following Heart Transplantation
17. CD4+ T Regulatory Cells and Modulation of Undesired Immune Responses
18. CAR Tregs protect alloimmune islets against autoimmune destruction
19. Sex biased human thymic architecture guides T cell development through spatially defined niches
20. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
21. Targeting regulatory T cell metabolism in disease: novel therapeutic opportunities
22. Strategies for optimizing CITE-seq for human islets and other tissues
23. T cell activation induced marker assays in health and disease
24. Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes
25. Human A2-CAR T cells reject HLA-A2+ human islets transplanted into mice without inducing graft versus host disease
26. Flagellin-specific human CAR Tregs for immune regulation in IBD
27. Manufacturing next-generation regulatory T-cell therapies
28. Integration of exogenous and endogenous co-stimulatory signals by CAR-Tregs
29. Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells
30. CD56brightCD16– natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
31. A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets
32. 216.6: Regulatory T Cell Biomarkers Identify Patients at Risk of Developing Acute Cellular Rejection in the First Year Following Heart Transplantation
33. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg)
34. Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation
35. PTEN is required for human Treg suppression of costimulation in vitro
36. The Women of FOCIS: Promoting Equality and Inclusiveness in a Professional Federation of Clinical Immunology Societies
37. PTEN is required for human Treg suppression of costimulation
38. Emerging strategies for treating autoimmune disorders with genetically modified Treg cells
39. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes
40. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
41. A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes
42. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
43. Helios is a marker, not a driver, of human Treg stability
44. Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections
45. Interactions between islets and regulatory immune cells in health and type 1 diabetes
46. Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers
47. Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity
48. The parasite cytokine mimic Hp‐TGM potently replicates the regulatory effects of TGF‐β on murine CD4+ T cells
49. Induction of stable human FOXP3+ Tregs by a parasite‐derived TGF‐β mimic
50. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.